/PRNewswire/ HanBio Therapeutics ("HanBio"), a biotechnology company committed to researching and developing next generation transformative medicines, today.
Rare diseases - Rare diseases, Pharmaceutical, France thepharmaletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepharmaletter.com Daily Mail and Mail on Sunday newspapers.
Drugmaker Sanofi SA will buy Amunix Pharmaceuticals Inc for an upfront payment of about $1 billion, marking the latest acquisition by the French drugmaker in the U.S. biotech sphere as Sanofi aims. | December 21, 2021
Drugmaker Sanofi SA will buy Amunix Pharmaceuticals Inc for an upfront payment of about $1 billion, marking the latest acquisition by the French drugmaker in the US biotech sphere as Sanofi aims to offset Covid-19 vaccine setbacks. Sanofi, under pressure to revive its drug pipeline and eager to overcome setbacks in the Covid-19 vaccine race, added on Tuesday that it will also